ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote 2 June 27, 2014Vol.40 No.26
ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote June 27, 2014Vol.40 No.26By Paul Goldberg and Tessa Vellek
In Brief Bayer Pharma AG and arGEN-X collaborate to develop therapeutic antibodies June 20, 2014Vol.40 No.25
In Brief Dana-Farber Cancer Institute and Trovagene Inc. begin collaboration June 20, 2014Vol.40 No.25
In Brief Yeshiva University and Montefiore Health System agree on new management structure for Albert Einstein College of Medicine June 20, 2014Vol.40 No.25
